148 related articles for article (PubMed ID: 1779173)
1. Epitope- and antigen-specific cancer vaccines.
Herlyn D; Linnenbach A; Koprowski H; Herlyn M
Int Rev Immunol; 1991; 7(4):245-57. PubMed ID: 1779173
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
[TBL] [Abstract][Full Text] [Related]
4. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis.
Velge-Roussel F; Auriault C; Damonneville M; Capron A
J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.
Maruyama H; Benden A; Li W; Zaloudik J; Koido T; Taupin JL; Acres B; Somasundaram R; Prewett M; Herlyn D
Int J Cancer; 1996 Feb; 65(4):547-53. PubMed ID: 8621241
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in antitumor vaccines.
Hu SL; Hellström I; Hellström KE
Biotechnology; 1992; 20():327-43. PubMed ID: 1318138
[TBL] [Abstract][Full Text] [Related]
11. CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
Pohl C; Renner C; Schwonzen M; Schobert I; Liebenberg V; Jung W; Wolf J; Pfreundschuh M; Diehl V
Int J Cancer; 1993 May; 54(3):418-25. PubMed ID: 8389737
[TBL] [Abstract][Full Text] [Related]
12. Functional mimicry of tumor-associated antigens by antiidiotypic antibodies.
Herlyn D; Wettendorff M; Iliopoulos D; Koprowski H
Exp Clin Immunogenet; 1988; 5(4):165-75. PubMed ID: 3078570
[TBL] [Abstract][Full Text] [Related]
13. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
14. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2.
Raychaudhuri S; Kang CY; Kaveri SV; Kieber-Emmons T; Köhler H
J Immunol; 1990 Jul; 145(2):760-7. PubMed ID: 2164069
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotype vaccine against cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
Pohl C; Renner C; Schwonzen M; Sieber M; Lorenz P; Pfreundschuh M; Diehl V
Int J Cancer; 1992 Apr; 50(6):958-67. PubMed ID: 1313400
[TBL] [Abstract][Full Text] [Related]
17. [Experimental induction of immunity by anti-idiotypic vaccines against small-cell-lung cancer].
Li Y; Hu JY; Zhang Y; Zhu MJ; Zhao XT
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):269-72. PubMed ID: 15996316
[TBL] [Abstract][Full Text] [Related]
18. Anti-idiotype cancer vaccines: past and future.
Herlyn D; Somasundaram R; Li W; Maruyama H
Cancer Immunol Immunother; 1996 Oct; 43(2):65-76. PubMed ID: 8954140
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
Raychaudhuri S; Saeki Y; Fuji H; Kohler H
J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
[TBL] [Abstract][Full Text] [Related]
20. Anti-idiotypic monoclonal antibody cancer vaccines.
Chapman PB
Semin Cancer Biol; 1995 Dec; 6(6):367-74. PubMed ID: 8938275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]